The Push for Generics Challenges Manufacturers

Biotech firms face new issues as FDA weighs policies to streamline generic-drug approvals and reduce patent disputes.

Related Content:

Quality SystemsRegulatory Oversight and ComplianceFormulation and Drug DeliveryDosage FormsPharmaceutical Technology-07-02-2003

A CDMO’s Role in API Quality

FDA Grants Fast Track Designation to Teva Celiac Disease Candidate

GSK, Spero Therapeutics Oral UTI Treatment Trial Stopped Early for Efficacy